BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27099495)

  • 1. Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers.
    Kamalapuram SK; Kanwar RK; Roy K; Chaudhary R; Sehgal R; Kanwar JR
    Int J Nanomedicine; 2016; 11():1349-66. PubMed ID: 27099495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging.
    Roy K; Kanwar RK; Kanwar JR
    Biomaterials; 2015 Dec; 71():84-99. PubMed ID: 26318819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism.
    Mahidhara G; Kanwar RK; Roy K; Kanwar JR
    Int J Nanomedicine; 2015; 10():4081-98. PubMed ID: 26124661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy.
    Kanwar JR; Mahidhara G; Kanwar RK
    Nanomedicine (Lond); 2012 Oct; 7(10):1521-50. PubMed ID: 22734611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotheranostic Based Iron Oxide (Fe₃O₄) Saturated Lactoferrin Nanocapsules for Colonic Adenocarcinoma.
    Kamalapuram SK; Kanwar RK; Kanwar JR
    J Biomed Nanotechnol; 2016 Sep; 12(9):1758-73. PubMed ID: 29345887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal iron oxide (Fe3O4)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER(-)/PR(-)/HER2(-)).
    Kanwar JR; Kamalapuram SK; Krishnakumar S; Kanwar RK
    Nanomedicine (Lond); 2016 Feb; 11(3):249-68. PubMed ID: 26785603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc.
    Kanwar JR; Mahidhara G; Roy K; Sasidharan S; Krishnakumar S; Prasad N; Sehgal R; Kanwar RK
    Nanomedicine (Lond); 2015 Jan; 10(1):35-55. PubMed ID: 25017148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism.
    Gupta I; Sehgal R; Kanwar RK; Punj V; Kanwar JR
    Nanomedicine (Lond); 2015; 10(8):1289-314. PubMed ID: 25442715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii.
    Anand N; Sehgal R; Kanwar RK; Dubey ML; Vasishta RK; Kanwar JR
    Int J Nanomedicine; 2015; 10():6355-69. PubMed ID: 26504384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.
    Roy K; Patel YS; Kanwar RK; Rajkhowa R; Wang X; Kanwar JR
    Int J Nanomedicine; 2016; 11():25-44. PubMed ID: 26730188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo toxicity assessment of alginate/eudragit S 100-enclosed chitosan-calcium phosphate-loaded iron saturated bovine lactoferrin nanocapsules (Fe-bLf NCs).
    Leng KM; Vijayarathna S; Jothy SL; Sasidharan S; Kanwar JR
    Biomed Pharmacother; 2018 Jan; 97():26-37. PubMed ID: 29080455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics.
    Sun Y; Yan C; Xie J; Yan D; Hu K; Huang S; Liu J; Zhang Y; Gu N; Xiong F
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29536-29548. PubMed ID: 31333014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant enzyme activities of iron-saturated bovine lactoferrin (Fe-bLf) in human gut epithelial cells under oxidative stress.
    Burrow H; Kanwar RK; Kanwar JR
    Med Chem; 2011 May; 7(3):224-30. PubMed ID: 21486205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast cancer.
    AbdElhamid AS; Zayed DG; Helmy MW; Ebrahim SM; Bahey-El-Din M; Zein-El-Dein EA; El-Gizawy SA; Elzoghby AO
    Nanomedicine (Lond); 2018 Oct; 13(20):2637-2656. PubMed ID: 30338705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tunable fabrication of new theranostic Fe
    Saeed M; Iqbal MZ; Ren W; Xia Y; Khan WS; Wu A
    J Mater Chem B; 2019 Jan; 7(2):210-223. PubMed ID: 32254547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis.
    Samarasinghe RM; Kanwar RK; Kanwar JR
    Biomaterials; 2014 Aug; 35(26):7522-34. PubMed ID: 24933511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer.
    Gibbons JA; Kanwar JR; Kanwar RK
    BMC Cancer; 2015 May; 15():425. PubMed ID: 25998617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice.
    Iigo M; Kuhara T; Ushida Y; Sekine K; Moore MA; Tsuda H
    Clin Exp Metastasis; 1999 Feb; 17(1):35-40. PubMed ID: 10390145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics.
    Wang Z; Ju Y; Ali Z; Yin H; Sheng F; Lin J; Wang B; Hou Y
    Nat Commun; 2019 Sep; 10(1):4418. PubMed ID: 31562357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
    Abdelmoneem MA; Elnaggar MA; Hammady RS; Kamel SM; Helmy MW; Abdulkader MA; Zaky A; Fang JY; Elkhodairy KA; Elzoghby AO
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26731-26744. PubMed ID: 31268657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.